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Prostate-specific antigen in the cerebrospinal fluid
leads to diagnosis of solitary cauda equina metastasis:
a unique case report and review of the literature
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Summary A 79-year-old male patient presented with a subacute cauda syndrome caused by an intradural metastasis of the lumbosacral
caudate fibres from an adenocarcinoma of the prostate, which had been treated 5 years earlier with external beam radiation therapy.
Diagnosis could not be established by repeated magnetic resonance images (MRIs) during a 2-year period of increasingly severe radicular
pain. Eventually, a small tumour mass could be visualized on the fourth MRI. Repeated normal serum prostate-specific antigen (PSA) did not
hint at a prostate cancer metastasis (range 2.4-5.1 ng ml-1); however, PSA in the cerebrospinal fluid was found to be elevated (29.1 ng ml-').
Empirical radiation therapy of the caudate region did not improve radicular pain. Therefore, an exploratory surgical procedure was conducted,
which confirmed the suspicion of an intradural prostate cancer metastasis. In conclusion, PSA in the cerebrospinal fluid provides a useful
diagnostic tool for detecting intradural prostate cancer metastasis.
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Clinically occult carcinoma of the prostate has been found at
autopsy series in around 70% of men over the age of 80 (Grant
et al, 1994; Oschmann et al, 1994). In manifest disease with
metastatic spread, skeletal, pulmonary as well as hepatic metas-
tases predominate (Elkin and Mueller, 1954), but intradurally
located metastases of the spinal axis are uncommon. Since 1950,
59 patients with histologically confirmed intradural spinal metas-
tasis have been found in scattered reports (Perrin et al, 1982; Chow
and McCutcheon, 1996), containing only one case of prostate
cancer. It is, however, generally accepted that the blood-brain
barrier has to be disrupted in intradural carcinomatosis (Siegal et
al, 1987), and therefore that haematogenous dissemination from
the primary tumour as well as spinal or epidural metastases by
embolization may be the most important and common mechanism
for spread of tumour cells into the spinal subrachnoid space
(Perrin et al, 1982; Chow and McCutcheon, 1996).
CASE REPORT
A 79-year old man was evaluated for a 3-year history of increas-
ingly severe radicular pain projecting into the left lumbosacral
dermatomes. His medical history included a prostate cancer (T3,
NO, MO) diagnosed 5 years earlier by a needle biopsy (moderately
differentiated adenocarcinoma of the prostate) and treated with
fractionated external beam radiation therapy (45 MeV, 6000 cGy
cumulative). Two years later, a radicular pain syndrome developed
insidiously, projecting into the left-sided lumbosacral dermatomes
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L5-S3 and accompanied by a diminished left side motor function
(abductor muscle BMA grade 4, iliopsoas muscle grade 4-5,
quadriceps muscle grade 4-5, gastrocnemius muscle grade 0-1,
peroneus muscle grade 0-1, extensor hallucis longus and digi-
torum brevis muscles grade 0-1) as a pronounced hypalgesia in
the left dermatomes L4-S1. There was urinary and bowel inconti-
nence. Because radicular pain intensified, clinical and laboratory
tests [prostate-specific antigen (PSA), prostate-specific acid phos-
phatase (PAP), cerebro-spinal fluid (CSF) cytology, CSF infec-
tion] were repeated every 6 months over the next 2 years with no
pathological findings. Radiological investigations using abdom-
inal ultrasound, excretory urography, skeletal scintigraphy and
abdominal computerized tomography (CT) could not detect
metastatic disease; even repeated myelographic and magnetic
resonance imaging (MRI) studies did not show signs of
lumbosacral metastasis (Figure 1). The serum PSA level too was
found to be within normal range, but steadily increasing in the
range 2.4-5.1 ng ml-' (Figure 2). A lumbar puncture showed a
PSA in the CSF of29 ng ml-' [a main part offree PSA and a minor
part of PSA complexed with alpha-1 -anti-chymotrypsin (ACT)]
and serum PSA was 5.1 ng ml-' (a minor part of free PSA and a
main part of PSA complexed with ACT). The method used to
measure PSA concentration has been described previously in
detail (Huber et al, 1995). The fourth MRI of the lumbar spine
showed an intradural, hypointense lesion likely to be a metastasis
of the cauda fibre between L5 and S3 (Figure 3) on T2-weighted
and T1-weighted images, clearly enhanced after administration of
gadolinium-Dota (Dotarem Guerbet Laboratoires, Paris, France).
The pronounced pain syndrome was treated empirically with
external beam radiation therapy ofthe spine (25 MeV), which had
to be interrupted after a total dose of32 Gy because ofprogression
and cast doubt on the metastatic nature ofthe lesion. Therefore, an
explorative laminectomy L5-S3 was conducted. After opening the
dural sac, caudate fibres were found to be surrounded by hard
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Figure 2 Line chart showing the course of PSA during illness. PSA in
serum under 10 ng ml-' is indicated as normal value. Time 0 means the
beginning of radiation therapy of the prostate. C, PSA (serum); A, PSA
(CSF)
fibrous tissue that was partially removed. Histological examina-
tion revealed a poorly differentiated carcinoma of the prostate
(Gleason grade 4; Gleason, 1966). The post-operative course was
uneventful.
Eighteen months after surgical exploration, the patient's condi-
tion showed progressive neurological detoriation. Gonadotropin-
releasing hormone analogues had been administered for 3 months
without effect. Orchiectomy was declined by the patient.
DISCUSSION
Figure 1 Ti -weighted magnetic resonance images in sagittal plane before
(A) and axial plane after (B) contrast administration. No evidence of tumour
in the lumbosacral spinal canal
We present a unique case of an intradural metastasis from prostate
cancer in which the exclusive elevation ofcerebrospinal fluid PSA
was instrumental in establishing the diagnosis. In addition, this is
the second case report of a histologically proven intradural
extramedullary spinal metastasis originating from prostate carci-
noma since 1959.
The criteria for leptomeningeal carcinomatosis are not uniform,
but can usually be established when two or more anatomical
regions of the central nervous system are involved (Olson et al,
1974). It is often misinterpreted as chemotherapy- or radiotherapy-
induced polyneuropathy or meningoradiculitis (Schuknecht et al,
1982), which may cause a substantial delay in definite diagnosis.
Gadolinium (Gd)-enhanced MR imaging has been shown to be
superior to myelography and to CT/myelography in localizing
intradural metastatic lesions (Sze et al, 1988). But even with the
most sensitive technique - Gd-enhanced MR imaging - one-third
of cases with proven meningeal carcinomatosis were missed (Sze
et al, 1989), or diagnosis was delayed as in our case. Probably
because high-signal CSF in T2-weighted sequences renders high-
signal subarachnoid lesions inperceptible and accounts for its
low sensitivity and the limited value of T2-weighted images
(Schuknecht et al, 1982).
The finding of malignant cells in the CSF cytology is difficult,
as several lumbar punctures might be required. The false-negative
rate ranges from 27% to 90% (Elkin and Mueller, 1954;
Oschmann et al, 1994), more often in cases of focal than dissemi-
nated disease (Chow and McCutcheon, 1996). An important
feature in this patient was the elevated PSA in the CSF with low
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Figure 3 Control magnetic resonance
examination 2 years after onset of
symptoms. Sagittal T2-weighted images
(A) show a spindle-like lesion intradural
on the level of L5-S3 (arrow). Axial Ti-
weighted image (B) before contrast
administration shows a slightly
hyperintense tumour in comparison with
CSF, with almost total occlusion of the
dural sack (arrowheads). On saggital
gadolinium enhanced Ti -weighted
images (C) the tumour shows a
homogeneous enhancement with
intermediate signal intensity (curved
arrow)
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PSA levels in the serum. ACT, one of the two major proteinase
inhibitors ofactive PSA zymogen, is present in serum as well as in
the CSF, in the former in higher concentrations (Lilja et al, 1992;
Huber et al, 1995; Oishi et al, 1996). Because the complex forma-
tion of PSA with its inhibitor ACT is stable, the elevated concen-
trations ofcomplex formation ofPSA with its inhibitor ACT in the
CSF as compared with the serum proves a real intrathecal secre-
tion of PSA (Lilja et al, 1992). The small volume ofthe intradural
spinal metastasis may not have produced enough PSA in the CSF
to pass the moderately altered blood-CSF barrier (albumin
quotient 23.0, IgG index 6.4) and build up a serum PSA level
above threshold. This clearly shows that assessment of the PSA
level in the CSF is a useful diagnostic tool for detecting intradural
prostate cancer metastasis. It is not clear whether the slight
increase in serum PSA signifies recurrence or variations within
normal range (Figure 1).
Although patients with untreated leptomeningeal carcino-
matosis generally die within 4-8 weeks from the time ofdiagnosis
(Olson et al, 1974), the rare cases of focal intradural metastatic
disease may be approached surgically to establish diagnosis or to
excise the lesion (Chow and McCutcheon, 1996). However, Chow
and McCutcheon (1996) presented two of ten cases of focal
meningeal carcinomatosis (alveolar soft-part sarcoma, poorly
differentiated adenocarcinoma with no known primary tumour)
with a post-operative survival of more than 1 year after surgery. In
the special case of established metastatic prostate cancer, anti-
androgen therapy is primary treatment that may be supplemented
with regional radiation therapy.
CONCLUSION
Histologically confirmed intradural spinal metastasis is a rare event.
Even with the most sensitive techniques, the diagnosis of such a
lesion is difficult and often delayed by several months or years. The
assessment of PSA in the CSF can be useful in establishing the
diagnosis of spinal intradural metastasis from prostate cancer, even
if serum PSA levels are normal.
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